- J.P. Morgan Global High Yield & Leveraged Finance Conference, February 28, 2012
- Alembic Global Advisors Chemical Conference, March 1 and 2, 2012
Jim Cramer likes Xilinx and Abbott Labs, but he's bearish on Xerox and Huntsman.
Comey's testimony? U.K. elections? Eurozone news? These can be new buying opportunities, says Jim Cramer.
The Huntsman-Clariant deal has the makings of an inversion -- and it may be a sign of hopes the Trump administration will ease regulations on such cross-border deals.
Donald Trump gives Wall Street a burst of relief on Monday after causing worry on markets for the previous two weeks.